Zu den Inhalten springen

Comprehensive Cancer Center Freiburg - CCCF

Research at the Comprehensive Cancer Center Freiburg – CCCF

From foundations to clinical applications

The dual focus of our efforts is to offer our patients interdisciplinary, innovative, and comprehensive care and to promote translational cancer research.
In the context of clinical trials, we can provide patients with the earliest possible access to promising new diagnostic and therapeutic concepts. The patients in question thus benefit from novel scientific approaches. The translation of research findings into clinical trials is facilitated by the Clinical Trials Unit and by early clinical trial units (ECTU) for adults and for children.


Research Groups at CCCF


Dr. B. Rautenberg

Breast Cancer (in German)

Dr. B. Rautenberg Ovarian Cancer (in German)
Prof. Dr. M. Klar Uterine cancer (in German)


Bone Metastases

AG Schmal/ Herget Bone metastases


Liver Metastases

Department of General and Visceral Surgery Liver surgery


Medical Bioinformatics and Systems Medicine



Prof. Dr. O. Schnell Translational NeuroOncology Research Group
PD Dr. D.H. Heiland Microenvironment and Immunology Research Laboratory
Fr. PD Dr. M.S. Carro Genetics of Brain Tumors Research Group
Fr. Prof. Dr. M. Machein Neurooncological Health Care Research Group
Prof. Dr. J.-H. Klingler, Fr. Dr. C. Steiert Hemangioblastoma and von Hippel-Lindau (VHL) Disease Research Group
Prof. Dr. T. Ball Neuromedical AI Lab
Prof. Dr. O. Schnell, Fr. Dr. D. Cipriani Clinical Trial Unit


Esophageal Carcinoma





AG Pancreas Oncological questions


Scientific Coordinator

PD Dr. Tanja Hartmann
Telephone: +49 (0)761 270-71511

Hartmann Research Group

  • .